EpiCypher develops and manufactures novel tools for epigenetics and chromatin biology research. EpiCypher was founded in 2012 by Mark Bedford, Or Gozani and Brian Strahl and has developed a wide portfolio of best in class products. Our innovation is a direct result of the scientific power associated with our founders, researchers and collaborators. We serve customers in a broad range of markets, enabling the adoption of epigenetic solutions in research and drug development. Bringing significant know-how and a commitment to innovation, collaboration and quality, we work with our customers to help solve research challenges and develop the most efficient path forward for your project .